We have produced a plasmid expression vector for the coat protein of RNA bacteriophage MS2. The vector has been modified to introduce a unique Kpni restriction site within the coat protein gene at a site corresponding to the most radially distant feature of the bacteriophage capsid, namely the top of the N-terminal fl-hairpin (between residues 15 and 16). Insertion of DNA oligonucleotides at this site allows the production of chimeric MS2 coat proteins having foreign peptide sequences expressed as the central part of the hairpin. We have produced chimeras with a number of different peptide sequences (up to 24 amino acids in length) chosen because of their known antigenic properties. The chimeric coat proteins self-assemble into largely RNAfree phage-like capsids in Escherichia coli and can be easily disassembled and reassembled in vitro. Such peptide-presenting particles may have a number of biotechnological applications, including use as a costeffective, synthetic vaccine. We have tested the antigenicity of one such construct in vivo in mice and have shown that these particles are immunogenic and that antibody titres against the inserted peptide epitope can be obtained.
Introduction
Although small linear peptides are capable of eliciting the production of antibodies that react with proteins containing the sequences as continuous epitopes, the peptides themselves are poor antigens (Porter & Whelan, 1986) . The classical approach to improving immunogenicity involves chemical coupling of the peptide to large carrier molecules, such as keyhole limpet haemocyanin (KLH) and/or use of an adjuvant on administration (Harlow & Lane, 1988) . Several groups have attempted an alternative route of peptide epitope presentation using genetic engineering to introduce foreign peptide sequences into the coat proteins of simple viruses in the hope that the epitope will be presented as part of the assembled viral capsid (Smith, 1985; Clarke et al., 1987; Dedieu et at., 1992) . A great deal of effort has been directed towards the use of filamentous bacteriophages for this purpose (Scott & Smith, 1990; Greenwood et al., 1991) . Here we present results with an alternative bacteriophage system, namely the simple spherical RNA bacteriophage MS2, which may have a number of advantages over the filamentous phage systems.
MS2 is a male-specific coliphage which has been t Present address : Department of Biology, Yale University, Kline Biology Tower 844, P.O. Box 6666, New Haven, Connecticut 06511, U.S.A. extensively characterized genetically and biochemically (Fiers, 1979) . The genome consists of a positive-sense ssRNA of 3569 bases, which is encapsidated in a T = 3 surface lattice containing 180 copies of a single coat protein subunit (M r 13-75K). The mature phage also contains one copy of the maturation protein (the product of the A gene), which functions during the phage life cycle by binding to bacterial pill and is taken up into the host bacterium with the phage RNA, whilst the remaining coat protein subunits are dissociated. The phage genome encodes just two other polypeptides, a replicase subunit and a lysis protein, which is produced later in infection to allow escape from the host cell. Neither of these proteins is part of the final capsid.
The structure of the phage capsid is known at atomic resolution from X-ray crystallography, although the position of the A protein was not revealed by the electron density map (Valegfird et al., 1990) . The coat protein subunit is unusual in that it does not have the conserved anti-paralM fl-barrel topology seen in virtually every other spherical RNA virus coat protein structure (Rossmann & Johnson, 1988) . In the phage capsid the coat proteins are packaged as non-covalent dimers which are secured by interdigitation of C-terminal 0~-helices from each monomer. Underneath the helices lies an extensive fl-sheet comprising five fl-strands from each subunit, whereas at the N terminus of the protein the polypeptide is folded into a fl-hairpin structure which forms the most radially distant feature of the mature 0001-1362 © 1993 SGM capsid (Fig. 1) . A feature of the structures of simple viruses which must avoid immune neutralization is the introduction of extended polypeptide loops, which are the immunodominant epitopes, in otherwise conserved three-dimensional folds (Rossmann & Johnson, 1988 Transformants were screened for inserts in the correct orientation by subcloning into M 13mpl 8 as above and dideoxynucleotide sequencing (Sanger et al., 1977) using the Pharmacia LKB Biotechnology TTSequencing Kit.
Expression and purification of MS2 antigen chimeras. Recombinant MS2 proteins were expressed as follows: 500 ml cultures of E. coli TG 1 carrying the appropriate pTACH-ACP or pTACH-CP vectors were grown at 37 °C to an absorbance (at 600 nm; A600) of approximately 0.4 to 0.6 and induced by the addition of isopropyl-fl-o-thiogalactoside (IPTG) to 1 mM and incubation continued overnight.
Soluble chimeras were purified as follows. Cells were harvested by centrifugation and the pellets resuspended in 50 mM-HEPES, 100 mMNaCI, 10 mM-DTT, 5 mM-EDTA, pH 7.4, sonicated for 15 min in 15 s bursts followed by 30 s rest periods on ice, and then clarified by centrifugation before the addition of magnesium acetate and DNase I to final concentrations of 6 mM and 10 lag/ml respectively. The mixture was incubated at 37 °C for 30 min to digest contaminating nucleic acids. The slight precipitate that formed was removed by centrifugation, and the MS2 protein in the supernatant was recovered by precipitation with ammonium sulphate. The ammonium sulphate pellet was then dialysed extensively against the resuspension buffer without DTT before being layered onto 15 to 45% (w/v) linear sucrose density gradients formed above a 60 % (w/v) sucrose cushion, and centrifuged at 28000 r.p.m, at 4 °C for 5 h in a Beckman Ti45 rotor. The peak of absorbance corresponding to assembled material was pooled and further purified over a size exclusion column (Bio-Gel A-1.5M, 5 x 160 cm). Fractions containing pure coat protein were pooled, ammonium sulphate-concentrated and stored at 4 °C until use.
Largely insoluble chimeras were purified by following the procedure outlined by Cheadle et al. (1992) . E. coil cell pellets were obtained as above and then resuspended in 2 x volume of 50 mM-HEPES, 6 M-urea, pH 7.4 by stirring overnight at 4 °C. Next, the sample was clarified by centrifugation (27 000 g), 4 °C for 30 min, the supernatant was decanted and diluted to 1 M-urea using 50 mM-HEPES pH 7.4 and 2 ml aliquots were applied to a size exclusion column (Bio-Gel A-1.5M, 5 x 160 cm) which had been previously equilibrated with 50 mM-HEPES, 1 M-urea, pH 7-0 at 4 °C. Fractions (2 ml) were collected at 0-25 ml/min and those containing essentially pure coat protein, as determined by SDS-PAGE, pooled. The coat protein sample was refolded over a rapid desalting column (Pharmacia H R 10/10) in 20 mM-HEPES, 0.1 M-DTT, pH 7"4 and the sample was stored overnight at 4 °C, before being applied to a size exclusion column (Pharmacia Superose-12) equilibrated in the same buffer. The fractions containing the reassembled chimeric capsids were then pooled.
Immunization protocols. TUXCS Number One mice and New
Zealand White rabbits were used for the immunization protocols. Five mice were injected subcutaneously at one site with 500 gg of purified MS2-WT (wild-type) or MS2-HA chimeric construct, absorbed on aluminium hydroxide (Alhydrogel) as adjuvant. Two rabbits were injected intradermally at three sites with 1 mg of purified construct in PBS containing no adjuvant. For the mice booster injections were given on days 14, 21 and 26 and blood was collected via the marginal tail vein. For the rabbits boosters were given on week 6, subcutaneously at three sites, and at week 8, intravenously. Blood was collected via the marginal ear vein. Sera were stored at -70 °C until use.
ELISA. The ELISA procedure followed the method originally described by Engvall & Perlmann (1971) . Briefly the antigen of interest [50 gl of a 50 gg/ml stock solution in 10 raM-sodium phosphate, 100 mM-sodium chloride pH 7.4 (PBS)] was dispensed into every well of a flat-bottom 96-well polyvinyl chloride or polystyrene microtitre plate using a multichannel pipetter and the plate incubated overnight at 4 °C. washer/aspirator (Labsystems Autowash II). The wells were then treated with BSA (1% w/v in PBS) for 1 h at 25 °C to block nonspecific binding sites, washed to remove excess solution and aspirated as above. The primary antibody was diluted 1 : 10 with PBS and the titre of this solution determined by successive 1 : 1 dilutions along a row of wells. A 50 ~tl aliquot was applied to each well and the plates were incubated at 25 °C for 2 h, washed/aspirated as above and the secondary antibody [e.g. goat anti-mouse IgG conjugated to horseradish peroxidase (HRP)] was added to each well, repeating the above incubation procedure. After the aspiration as above, a 50 ~tl aliquot of developer solution (100 mM-sodium citrate, 100 mM-sodium acetate, pH 5.0, containing 0-04% w/v 1,2-benzenediamine and 0-004% v/v hydrogen peroxide) was added to each well and incubated for 10 min at 25 °C. The enzyme reaction was quenched by the addition of 25 ~tl of 2 M-sulphuric acid. After 5 rain the A49 ~ values were measured using a Labsystems Multiscan Plus Plate Reader and the data analysed via an Olivetti PCS286 using Flexi Calc software. Synthetic peptides were covalently coupled to surface-modified polystyrene microtitre plates using established protocols for peptide antigens (Jemmerson, 1987; Larsson et al., 1989) .
SD~PAGE and Western blot analysis. SDS-PAGE for the analysis of proteins followed the procedure of Sh~igger & yon Jagow (1987) without alterations. Western blots followed the procedure ofTowbin et al. (1979) , but with the following alterations for preabsorption blots. To obtain sufficient quantities of antibody for the preabsorption assays rabbit anti-MS2-HA IgG was isolated and affinity-purified according to the methods described by Harlow & Lane (1988) . Three replicates of purified MS2-WT and MS2-HA proteins, and a synthetic nonapeptide covalently crosslinked to KLH using the method outlined by Gnann et al. (1989) , were separated on a 3 to 20% (w/v) SDS polyacrylamide linear gradient gel according to Laemmli (1970) and then electrophoretically blotted onto 0.2 lam nitrocellulose sheets. After blocking of non-specific sites with 1% (w/v) BSA, 0.5% (v/v) Tween 20 in PBS (30 min at 37 °C) the sheet was divided into thirds, and purified rabbit anti-MS2-HA IgG (at a titre of 1 : 800), undiluted or preabsorbed with MS2-WT at two different molar ratios of carrier molecule to antigen, was used as the primary probe. Visualization of the bands followed binding of HRP-linked goat anti-rabbit IgG (at a titre of 1 : 1000) and development of the peroxidase activity using the Amersham ECL (Western blotting detection system).
Results
To incorporate the foreign peptide sequences at the appropriate position, we have modified an existing clone of the MS2 coat protein gene (G. Medina & P.G. Stockley, unpublished results) using site-directed mutagenesis to incorporate the following changes in nucleotide sequence, A1380T and T1383C (n.b. sequence numbers are relative to the MS2 wild-type genome; Oligos used: The gpl20 insert was generated by first annealing the two oligonucleotides shown, treating with Klenow polymerase to make them double-stranded, T 4 polynucleotide kinase and DNA ligase to produce tandemly ligated fragments which were then digested with KpnI, before gel purification and cloning into prepared expression vectors. The other oligonucleotides were simply annealed and cloned directly. MS2-gp 120. The doublets in some lanes are due to cross-contamination between lanes during loading of the gel, Fiers, 1979) which produces a unique KpnI restriction enzyme cleavage site at position 1378 in the gene sequence (Fig. 2) . Synthetic DNA oligonucleotides corresponding to the sense and antisense strands of the foreign epitopes and carrying the appropriate flanking nucleotides for insertion at the KpnI site were then annealed and ligated into the expression construct. Positive clones in the correct orientation were then identified by DNA sequencing. This method of insertion results in duplication of the codons for glycine and threonine at positions 14 and 15 in the coat protein thus leading to the inserts being flanked by the sequence Gly-Thr. The size of the inserted non-MS2 sequences is thus increased by two to 11 amino acids for the HA sequence (MS2-HA), 12 amino acids for the human IgE (MS2-IgE), 14 amino acids for the malarial antigen (MS2-Mal), 22 amino acids for the HPV-16 inserts (MS2-L1 and MS2-L2) and 26 amino acids for the HIV sequence (MS2-gpl20). Two expression vectors have been used to produce the chimeric proteins. They are both derived from plasmids carrying the trp-lac' tac' hybrid promoter (Amann et al., 1983) . The first (pTACH + CP) is inducible with IPTG as expected but the second (pTACH-ACP) carries a copy of the bacteriophage A gene between the promoter and the coat protein gene. Sequences within this gene confer the property of high level constitutive expression on the coat protein cistron (Kastelein et al., 1983; de Smit & van Duin, 1990) . For both vectors SDS-PAGE analysis of ceils carrying the appropriate construct revealed production of polypeptides of the expected M r values, all of which reacted in Western blots with a rabbit anti-MS2 coat protein polyclonal serum (Fig. 3) . The chimeras containing the HA, IgE and gpl20 inserts also reacted with the appropriate insert-specific monoclonal antibodies (MAbs) (data not shown).
To purify the recombinant proteins and analyse the state of their aggregation, bacterial cell pellets were sonicated and the resultant solutions fractionated by low-speed centrifugation. SDS-PAGE of both pellet and supernatant fractions (not shown) from pTACH-ACP clones revealed that a significant proportion of the MS2-WT and the MS2-HA proteins remained in the supernatant whereas the other chimeras were largely in the pellet fraction. The soluble samples were then analysed on sucrose density gradients (Fig. 4a) in which a rapidly sedimenting fraction containing MS2 coat protein or its HA derivative was readily identified. Electron microscopy of this material showed it to be assembled phage-like particles of diameter approximately 250 A with a T = 3 morphology. Absorbance measurements at 260 and 280 nm suggested that these particles contain only very small amounts of nucleic acid and are in effect empty capsids. Fig. 3 were further fractionated as described in Methods. The A280 profile of the resultant sucrose density gradient profile is shown in the figure. Centrifugation is from left to right. The large peak in the centre of the gradient indicated by the arrowhead represents the pure MS2 coat protein (data not shown). (b) Electron micrographs of MS2 chimeras purified by immunoaffinity chromatography or after reassembly following urea solubilization. Samples were prepared as follows. Cells were grown at 30 °C and the initial supernatant after sonication was dialysed directly against 20 mN-sodium phosphate buffer pH 7.4 at 4 °C before being applied to an immunoaffinity column, which was then rinsed extensively with dialysis buffer and then the same buffer containing 100 mM-NaC1, before the MS2 proteins were eluted in 20 mMacetic acid, 200 mM-NaC1. The eluted proteins were immediately adjusted to pH 7.0 with 1 M-Tri~HC1 pH 9.0, concentrated by ammonium sulphate precipitation, resuspended in 10 mN-Tris HCI, 100 mM-NaC1, pH 7.0 and then dialysed against the same buffer before being prepared for electron microscopy using the negative staining protocol of Sugiyama et al. (1967) . Micrographs were produced using a JEM-1200 instrument at an accelerating voltage of 75 kV. The immunoaffinity column consists of affinity-purified rabbit anti-MS2 WT polyclonal IgGs covalently coupled to Affi-Gel Hz (Bio-Rad) according to the manufacturer's instructions (R. A. Mastico, unpublished results). Samples are: panel A, MS2-WT; B, M S , H A ; C, MS2-IgE; D, MS2-gpl20; E, MS2 L1; F, MS2-L2; G, MS~Mal.
The insolubility of the other chimeras and portions of the MS2-WT and MS2-HA proteins appears to be the result of constitutive expression in the pTACH-ACP vector system. However, soluble forms of all of the proteins were obtained from cells carrying the pTACH-CP vectors, particularly when the cells were grown at lower temperatures. Examination by electron microscopy of thin sections of the cells expressing chimeric proteins showed that all the chimeras produced assembled phagelike particles (data not shown) which then formed semicrystalline arrays similar to those observed in wild-type phage infections. These insoluble capsid aggregates could be solubilized from cell pellets by treatment with urea according to the procedure of Cheadle et al. (1992) and the disassembled, unfolded chimeric coat proteins purifled by gel filtration chromatography. Subsequent dilution to reduce the urea concentration resulted in the formation of soluble reassembled capsid-like particles as judged by electron microscopy. Alternatively the fraction of each chimera remaining soluble after sonication of the cell pellets could be purified by immunoaffinity chromatography on an anti-MS2 coat protein column and yielded essentially homogeneous material (Fig. 4) . N-terminal amino acid sequencing of the purified MS2-HA chimera over the first 30 residues confirmed the expected sequence for the insert.
To test the immunogenicity of the chimeric constructs the MS2-HA capsids were used. TUXCS Number One mice were immunized subcutaneously with a series of doses of sucrose gradient-purified empty capsids in a 1 : 1 R. A. Mastico, S. J. Talbot and P. G. Stockley mix (v/v) with the adjuvant Alhydrogel. Booster injections were given at 7 or 14 day intervals. The resultant response was characterized by ELISA using either MS2-HA or MS2-WT as the antigen on the plate (Harlow & Lane, 1988) . There was a roughly linear dose~esponse (data not shown). At the highest dose (500 gg MS2-HA corresponding to 36 gg of insert) the titre (expressed as the half maximum value of the A495) for the serum at day 42 was 1 : 7500 + 300 (Fig. 5) . When the carrier alone (i.e. MS2-WT) was used as antigen the titre fell to 1:3200_+130, an indication that specific antibody titres against the insert had been produced. The antisera also recognized the HA nonapeptide coupled to KLH, although with a considerably lower titre (1:700_+30). Similar anti-MS2-HA sera raised in BALB/c mice also recognized the HA nonapeptide covalently linked directly to the microtitre plate (1:950_+40). The specificity of the sera for the inserted peptide was also demonstrated by prior absorption with excess MS2 WT before use in ELISAs or Western blots against MS2-HA, MS2-WT and KLH-HA9, which showed the expected reactivity profile (Fig. 6 ). K L H -H A was detected only in non-preabsorbed sera (Fig. 6 a) .
Discussion
We have shown that a number of foreign peptide epitopes, up to 24 amino acids in length, can be inserted into the N-terminal/?-hairpin of the MS2 coat protein without significant detrimental effect on the ability of the expressed chimeric proteins to self-assemble into largely RNA-free capsid-like particles in vivo. This is consistent with the location of the hairpin in the phage capsid since it is not involved in any intermolecular contacts (Valegfird et al., 1990) . The expression construct does not include the MS2 replicase translational operator which is normally located 3' to the coat protein gene and is believed to function as the assembly initiation sequence (Beckett et al., 1988) . The formation of empty capsids upon coat protein expression is therefore accounted for (Rohrmann & Krueger, 1970) . Soluble forms of the chimeric capsids are easily purified, but even insoluble forms can be recovered by a simple cycle of disassembly and reassembly in the presence of urea. As expected from the external location of the inserted epitope, chimeric capsids are immunogenic and are able to elicit specific anti-insert responses. The HA9 peptide sequence, used in the immunogenicity study, was initially identified as a linear fragment capable of generating a strong immune response when presented as part of a synthetic peptide attached to a larger carrier protein (Green et al., 1982) . A MAb (Niman et al., 1983) to this peptide has a very high affinity and has been used to purify proteins fused to the nonamer sequence by affinity chromatography (Field et al., 1988) . The complex between the nonapeptide and the monoclonal Fab' has been crystallized and the structure determined by X-ray diffraction techniques (Rini et al., 1992) . In the antigen-binding site the peptide interacts with the protein over seven of the nine residues and forms a short extended chain which then forms a type I fl-turn. Comparison of the Fab' and Fab'-peptide complex structures suggests that the antibody undergoes significant conformational change upon antigen binding ('induced fit'). This implies that the interaction seen in the crystal structure is the lowest free energy form of the complex. It is interesting to speculate whether recognition of the same sequence within a polypeptide loop, i.e. in the context of the MS2 capsid structure, requires the same defined conformation of the peptide. An indication of this comes from the titres of the anti-HA nonamer MAb (Cas-125) for either MS2-HA (1:379_+25) or KLH-HA (1:3650_+273). The sharply reduced titre for the sequence in the MS2 loop presumably reflects the free energy cost of converting the nonamer into the conformation that is recognized, since the conformation change for the antibody is presumably the same in each case. This result suggests that expression of at least the HA nonamer sequence in the fl-hairpin loop constrains its conformation.
These experiments demonstrate the potential utility of the MS2 system for the presentation of foreign peptide sequences on the surface of a spherical bacteriophage capsid. The system has a number of advantages over the filamentous bacteriophage alternatives. The MS2 coat protein is capable of facile self-assembly in the absence of nucleic acid (Rohrmann & Krueger, 1970 ) unlike the filamentous phages in which assembly is concomitant with encapsidation of nucleic acid (Model & Russel, 1988) . Furthermore the filamentous coat protein must undergo post-translational processing and membrane insertion before assembly occurs whereas the MS2 protein is unprocessed. The MS2 system also has the advantage of a detailed molecular model for the coat protein allowing the effects of foreign peptide insertion to be modelled. The apparent ability of MS2 chimeras to produce specific titres against foreign epitopes suggests that they offer a cheap and elegant method for the production of refined vaccines. Indeed, there is no intrinsic reason why the coat protein could not be expressed in a heterologous host such as yeast which might even allow epitopes requiring post-translational modification to be presented.
A big advantage of the filamentous systems over the use of MS2 illustrated here is that expression of foreign peptides in the former system occurs on the surface of live phage containing the DNA encoding the insert. This has led to a number of applications using selection of phage expressing a mixture of inserted random sequences, the selected insert sequences being identified by subsequent phage amplification and DNA sequencing. In principle the same approach might work with MS2 provided that insertion of foreign sequences did not disrupt encapsidation of the genomic RNA. Experiments are in hand to test this idea.
